March 2019: Guyana conducts 3rd round of LF MDA

The Guyanese government is conducting its third round of a mass drug administration event to eliminate lymphatic filariasis in Guyana by 2020. The campaign, which begins this year, will employ the new triple-drug therapy IDA (ivermectin, diethylcarbamazine and albendazole) in all ten regions of Guyana as part of a preventative chemotherapy strategy to prevent the spread of the disease. In 2017, WHO recommended the adoption of IDA to further accelerate the global elimination of lymphatic filariasis. Stabroek News